Genetic basis of motoric cognitive risk syndrome in the Health and Retirement Study
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To examine polygenic inheritance of motoric cognitive risk syndrome (MCR), a predementia syndrome characterized by the presence of subjective cognitive complaints and slow gait.
Methods We analyzed 4,915 individuals, age 65 years and above, with European ancestry (mean age 75.0 ± 6.8 years, 56.6% women) in the Health and Retirement Study. Polygenic scores (PGS) were calculated as weighted sums of the effect of single nucleotide polymorphisms, with effect sizes derived from genome-wide association studies. The association between PGSs of 9 phenotypes (general cognition, body mass index [BMI], mean arterial pressure, education, Alzheimer disease [AD], neuroticism, well-being, waist circumference, and depressive symptoms) and MCR as well as its key components (cognitive complaints and slow gait) were examined by logistic regression, adjusting for age, sex, education, and genetic ancestry, and reported as odds ratios (ORs) with 95% confidence intervals (CIs).
Results There were 260 prevalent MCR cases, 529 with slow gait, and 1,928 with subjective cognitive complaints. Higher PGSs for BMI (OR 1.22, 95% CI 1.07–1.39) and waist circumference (OR 1.23, 95% CI 1.07–1.40) were associated with MCR, and PGS of AD showed a suggestive association (OR 1.16, 95% CI 1.02–1.32). Higher PGS for neuroticism (OR 1.10, 95% CI 1.03–1.18) was associated with cognitive complaints, whereas higher well-being PGS (OR 0.92, 95% CI 0.87–0.98) was protective. PGS for BMI (OR 1.16, 95% CI 1.06–1.28), waist circumference (OR 1.19, 95% CI 1.08–1.31), and AD (OR 1.13, 95% CI 1.03–1.24) was associated with slow gait.
Conclusion Obesity-related genetic traits increase risk of MCR syndrome; further investigation is required to identify potential therapeutic targets.
Glossary
- AD=
- Alzheimer disease;
- BMI=
- body mass index;
- CI=
- confidence interval;
- FDR=
- false discovery rate;
- GWAS=
- genome-wide association studies;
- HRS=
- Health and Retirement Study;
- LD=
- linkage disequilibrium;
- MCI=
- mild cognitive impairment;
- MCR=
- motoric cognitive risk;
- OR=
- odds ratio;
- PCA=
- principal components analysis;
- PGS=
- polygenic score;
- SNP=
- single nucleotide polymorphism
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received August 17, 2018.
- Accepted in final form November 21, 2018.
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Cumulative Genetic Risk and APOE ε4 Are Independently Associated With Dementia Status in a Multiethnic, Population-Based CohortKelly M. Bakulski, Harita S. Vadari, Jessica D. Faul et al.Neurology: Genetics, March 05, 2021 -
Article
Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MSMilena A. Gianfrancesco, Pernilla Stridh, Brooke Rhead et al.Neurology, March 29, 2017 -
Research Article
Development and Validation of a Polygenic Risk Score for Stroke in the Chinese PopulationXiangfeng Lu, Xiaoge Niu, Chong Shen et al.Neurology, May 24, 2021 -
Article
Polygenic risk of Alzheimer disease is associated with early- and late-life processesElizabeth C. Mormino, Reisa A. Sperling, Avram J. Holmes et al.Neurology, July 06, 2016